Skip to content

Xencor XNCR PP&E (Net)

PP&E (Net) at other companies

Amgen logo
AmgenAMGN
$8.22B+23.0%
Janux Therapeutics logo
Janux TherapeuticsJANX
$3.55M-28.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$8.29M-14.5%
Absci Corporation logo
Absci CorporationABSI
$18.78M-30.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$5.28M-7.0%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's PP&E (net)?
Xencor (XNCR) reported PP&E (net) of $51.49M in Q1 2026.
How has Xencor's PP&E (net) changed year-over-year?
Xencor's PP&E (net) decreased by 12.4% year-over-year, from $58.81M to $51.49M.
What is the long-term trend for Xencor's PP&E (net)?
Over 5 years (2020 to 2025), Xencor's PP&E (net) has grown at a 19.7% compound annual growth rate (CAGR), from $21.68M to $53.31M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.